NEW YORK (MainStreet) — Pfizer subsidiary Greenstore LLC is voluntarily recalling bottles of depression medication Citalopram and the popular prostate drug Finasteride, as their labels may have been switched by a third-party manufacturer.
The recall, announced late last week, applies to all Citalopram 10mg Tablets (100-count bottle) and Finasteride 5mg Tablets (90-count bottle) with Lot number FI0510058-A on the label. According to the Food and Drug Administration (FDA), bottles should be returned to patients’ pharmacists to verify contents.
Citalopram, a generic drug that also goes under the brand name Celexa, is used to treat depression, while Finasteride, also called Proscar and Propecia, is used to treat enlarged prostrates and male pattern baldness.
The FDA said that women who are or may become pregnant should not take or handle Finasteride since the drug may cause abnormalities to a developing male fetus.
Additionally, patients who inadvertently discontinue Citalopram by taking the mislabeled product may experience withdrawal symptoms and/or worsening of depression.
The FDA has advised consumers who are experiencing any problems related to either medication to contact their physician or health care provider. Adverse effects should also be reported to Pfizer at 1-800-438-1985 (open 24 hours) or to FDA's Med Watch Program either online, by regular mail or by fax at 1-800-FDA-0178.
This isn’t the first time that Pfizer has had to recall a product due to errors by a third-party manufacturer.
Last year, the company issued four separate recalls on more than 360,000 bottles of Lipitor, a prescription drug that treats high cholesterol and heart disease, after consumers reported an “uncharacteristic odor” upon opening the bottle. Pfizer said after its most recent Lipitor recall in December 2010 that the contaminated bottles were supplied by a third-party bottle manufacturer, which is no longer being used by the company.
—For the best rates on loans, bank accounts and credit cards, enter your ZIP code at BankingMyWay.com.